Prevalence of lymphoreticular prion protein accumulation in UK tissue samples
Corresponding Author
David A Hilton
Department of Histopathology, Derriford Hospital, Plymouth, UK
Department of Histopathology, Derriford Hospital, Plymouth, PL6 8DH, UK.Search for more papers by this authorAzra C Ghani
Department of Infectious Disease Epidemiology, Faculty of Medicine, Imperial College, London, UK
Search for more papers by this authorLisa Conyers
Department of Histopathology, Derriford Hospital, Plymouth, UK
Search for more papers by this authorPhilip Edwards
Department of Histopathology, Derriford Hospital, Plymouth, UK
Search for more papers by this authorLinda McCardle
National CJD Surveillance Unit, University of Edinburgh, Edinburgh, UK
Search for more papers by this authorDiane Ritchie
National CJD Surveillance Unit, University of Edinburgh, Edinburgh, UK
Search for more papers by this authorMark Penney
Department of Histopathology, Derriford Hospital, Plymouth, UK
Search for more papers by this authorDoha Hegazy
Department of Histopathology, Derriford Hospital, Plymouth, UK
Search for more papers by this authorJames W Ironside
National CJD Surveillance Unit, University of Edinburgh, Edinburgh, UK
Search for more papers by this authorCorresponding Author
David A Hilton
Department of Histopathology, Derriford Hospital, Plymouth, UK
Department of Histopathology, Derriford Hospital, Plymouth, PL6 8DH, UK.Search for more papers by this authorAzra C Ghani
Department of Infectious Disease Epidemiology, Faculty of Medicine, Imperial College, London, UK
Search for more papers by this authorLisa Conyers
Department of Histopathology, Derriford Hospital, Plymouth, UK
Search for more papers by this authorPhilip Edwards
Department of Histopathology, Derriford Hospital, Plymouth, UK
Search for more papers by this authorLinda McCardle
National CJD Surveillance Unit, University of Edinburgh, Edinburgh, UK
Search for more papers by this authorDiane Ritchie
National CJD Surveillance Unit, University of Edinburgh, Edinburgh, UK
Search for more papers by this authorMark Penney
Department of Histopathology, Derriford Hospital, Plymouth, UK
Search for more papers by this authorDoha Hegazy
Department of Histopathology, Derriford Hospital, Plymouth, UK
Search for more papers by this authorJames W Ironside
National CJD Surveillance Unit, University of Edinburgh, Edinburgh, UK
Search for more papers by this authorAbstract
This study aims to provide an estimate of the number of individuals in the UK who may be incubating variant Creutzfeldt-Jakob disease and at risk of causing iatrogenic spread of the disease. Lymphoreticular accumulation of prion protein is a consistent feature of variant Creutzfeldt-Jakob at autopsy and has also been demonstrated in the pre-clinical phase. Immunohistochemical accumulation of prion protein in the lymphoreticular system remains the only technique that has been shown to predict neurological disease reliably in animal prion disorders. In this study, immunohistochemistry was used to demonstrate the presence of prion protein, with monoclonal antibodies KG9 and 3F4, in surgically removed tonsillectomy and appendicectomy specimens. The samples were collected from histopathology departments across the UK and anonymised prior to testing. Samples were tested from 16 703 patients (14 964 appendectomies, 1739 tonsillectomies), approximately 60% of whom were from the age group 20–29 years at operation. Twenty-five per cent of the samples were excluded from the final analyses because they contained inadequate amounts of lymphoid tissue. Three appendicectomy samples showed lymphoreticular accumulation of prion protein, giving an estimated prevalence of 3/12 674 or 237 per million (95% CI 49–692 per million). The pattern of lymphoreticular accumulation in two of these samples was dissimilar from that seen in known cases of variant Creutzfeldt-Jakob disease. Although it is uncertain whether immunohistochemical accumulation of prion protein in the lymphoreticular system is specific for variant Creutzfeldt-Jakob disease, it has not been described in any other disease, including other forms of human prion disease or a range of inflammatory and infective conditions. These findings reinforce the importance of measures taken by the UK Department of Health to reduce the risk of spread of variant Creutzfeldt-Jakob via blood products and surgical instruments, and of the urgency to proceed with large-scale screening of fresh tonsil specimens for the presence of prion protein. Copyright © 2004 Pathological Society of Great Britain and Ireland. Published by John Wiley & Sons, Ltd.
REFERENCES
- 1Will RG, Ironside JW, Zeidler M, et al. A new variant of Creutzfeldt-Jakob disease in the UK. Lancet 1996; 347: 921–925.
- 2Bruce ME, Will RG, Ironside JW, et al. Transmissions to mice indicate that ‘new variant’ CJD is caused by the BSE agent. Nature 1997; 389: 498–501.
- 3Collinge J, Sidle KC, Meads J, Ironside J, Hill AF. Molecular analysis of prion strain variation and the aetiology of ‘new variant’ CJD. Nature 1996; 383: 685–690.
- 4Hill AF, Desbruslais M, Joiner S, et al. The same prion strain causes vCJD and BSE. Nature 1997; 389: 448–450.
- 5Majeed A, Lehmann P, Kirby L, Knight R, Coleman M. Extent of misclassification of death from Creutzfeldt-Jakob disease in England 1979–96: retrospective examination of clinical records. Br Med J 2000; 320: 145–147.
- 6Hillier CE, Salmon RL, Neal JW, Hilton DA. Possible underascertainment of variant Creutzfeldt-Jakob disease: a systematic study. J Neurol Neurosurg Psychiatry 2002; 72: 304–309.
- 7Anderson RM, Donnelly CA, Ferguson NM, et al. Transmission dynamics and epidemiology of BSE in British cattle. Nature 1996; 382: 779–788.
- 8Cousens SN, Vynnycky E, Zeidler M, Will RG, Smith PG. Predicting the CJD epidemic in humans. Nature 1997; 385: 197–198.
- 9Ghani AC, Ferguson NM, Donnelly CA, Anderson RM. Predicted vCJD mortality in Great Britain. Nature 2000; 406: 583–584.
- 10d'Aignaux JN, Cousens SN, Smith PG. Predictability of the UK variant Creutzfeldt-Jakob disease epidemic. Science 2001; 294: 1729–1731.
- 11Valleron AJ, Boelle PY, Will R, Cesbron JY. Estimation of epidemic size and incubation time based on age characteristics of vCJD in the United Kingdom. Science 2001; 294: 1726–1728.
- 12Ferguson NM, Ghani AC, Donnelly CA, Hagenaars TJ, Anderson RM. Estimating the human health risk from possible BSE infection of the British sheep flock. Nature 2002; 415: 420–424.
- 13Ghani AC, Donnelly CA, Ferguson NM, Anderson RM. Updated projections of future vCJD deaths in the UK. BMC Infect Dis 2003; 3: 4.
- 14Lloyd SE, Onwuazor ON, Beck JA, et al. Identification of multiple quantitative trait loci linked to prion disease incubation period in mice. Proc Natl Acad Sci U S A 2001; 98: 6279–6283.
- 15Anil MH, Love S, Helps CR, et al. Jugular venous emboli of brain tissue induced in sheep by the use of captive bolt guns. Vet Rec 2001; 148: 619–620.
- 16Bosque PJ, Ryou C, Telling G, et al. Prions in skeletal muscle. Proc Natl Acad Sci U S A 2002; 99: 3812–3817.
- 17Wadsworth JD, Joiner S, Hill AF, et al. Tissue distribution of protease resistant prion protein in variant Creutzfeldt-Jakob disease using a highly sensitive immunoblotting assay. Lancet 2001; 358: 171–180.
- 18Eklund CM, Kennedy RC, Hadlow WJ. Pathogenesis of scrapie virus infection in the mouse. J Infect Dis 1967; 117: 15–22.
- 19Kimberlin RH, Walker CA. Pathogenesis of scrapie in mice after intragastric infection. Virus Res 1989; 12: 213–220.
- 20Schreuder BE, van Keulen LJ, Vromans ME, Langeveld JP, Smits MA. Preclinical test for prion diseases. Nature 1996; 381: 563.
- 21Bradley R. BSE transmission studies with particular reference to blood. Dev Biol Stand 1999; 99: 35–40.
- 22Hill AF, Butterworth RJ, Joiner S, et al. Investigation of variant Creutzfeldt-Jakob disease and other human prion diseases with tonsil biopsy samples. Lancet 1999; 353: 183–189.
- 23Ironside JW, McCardle L, Horsburgh A, Lim Z, Head MW. Pathological diagnosis of variant Creutzfeldt-Jakob disease. APMIS 2002; 110: 79–87.
- 24Hilton DA, Fathers E, Edwards P, Ironside JW, Zajicek J. Prion immunoreactivity in appendix before clinical onset of variant Creutzfeldt-Jakob disease. Lancet 1998; 352: 703–704.
- 25Hilton DA, Ghani AC, Conyers L, et al. Accumulation of prion protein in tonsil and appendix: review of tissue samples. Br Med J 2002; 325: 633–634.
- 26Schreuder BE, van Keulen LJ, Vromans ME, Langeveld JP, Smits MA. Tonsillar biopsy and PrPSc detection in the preclinical diagnosis of scrapie. Vet Rec 1998; 142: 564–568.
- 27O'Rourke KI, Baszler TV, Besser TE, et al. Preclinical diagnosis of scrapie by immunohistochemistry of third eyelid lymphoid tissue. J Clin Microbiol 2000; 38: 3254–3259.
- 28Ironside JW, Hilton DA, Ghani A, et al. Retrospective study of prion-protein accumulation in tonsil and appendix tissues. Lancet 2000; 355: 1693–1694.
- 29Hilton DA. vCJD—predicting the future? Neuropathol Appl Neurobiol 2000; 26: 405–407.
- 30Sabattini E, Bisgaard K, Ascani S, et al. The EnVision++ system: a new immunohistochemical method for diagnostics and research. Critical comparison with the APAAP, ChemMate, CSA, LABC, and SABC techniques. J Clin Pathol 1998; 51: 506–511.
- 31Muramoto T, Kitamoto T, Tateishi J, Goto I. Accumulation of abnormal prion protein in mice infected with Creutzfeldt-Jakob disease via intraperitoneal route: a sequential study. Am J Pathol 1993; 143: 1470–1479.
- 32Ford MJ, Burton LJ, Morris RJ, Hall SM. Selective expression of prion protein in peripheral tissues of the adult mouse. Neuroscience 2002; 113: 177–192.
- 33Hilton DA, Sutak J, Smith MEF, et al. Specificity of lymphoreticular accumulation of prion protein for variant Creutzfeldt-Jakob disease. J Clin Pathol 2004; 57: 300–302.
- 34Head MW, Ritchie D, Smith N, et al. Peripheral tissue involvement in sporadic, iatrogenic, and variant Creutzfeldt-Jakob disease: an immunohistochemical, quantitative, and biochemical study. Am J Pathol 2004; 164: 143–153.
- 35Parchi P, Giese A, Capellari S, et al. Classification of sporadic Creutzfeldt-Jakob disease based on molecular and phenotypic analysis of 300 subjects. Ann Neurol 1999; 46: 224–233.
- 36Chou I. Strain of unknown prions weighs heavily on Japan, Italy. Nature Med 2003; 9: 1442.
- 37Brown P, Gibbs CJ Jr, Rodgers-Johnson P, et al. Human spongiform encephalopathy: the National Institutes of Health series of 300 cases of experimentally transmitted disease. Ann Neurol 1994; 35: 513–529.
- 38Korth C, Stierli B, Streit P, et al. Prion (PrPSc)-specific epitope defined by a monoclonal antibody. Nature 1997; 390: 74–77.
- 39Paramithiotis E, Pinard M, Lawton T, et al. A prion protein epitope selective for the pathologically misfolded conformation. Nature Med 2003; 9: 893–899.
- 40Race R, Raines A, Raymond GJ, Caughey B, Chesebro B. Long-term subclinical carrier state precedes scrapie replication and adaptation in a resistant species: analogies to bovine spongiform encephalopathy and variant Creutzfeldt-Jakob disease in humans. J Virol 2001; 75: 10 106–10 112.
- 41Asante EA, Linehan JM, Desbruslais M, et al. BSE prions propagate as either variant CJD-like or sporadic CJD-like prion strains in transgenic mice expressing human prion protein. EMBO J 2002; 21: 6358–6366.
- 42Bruce ME, McConnell I, Will RG, Ironside JW. Detection of variant Creutzfeldt-Jakob disease infectivity in extraneural tissues. Lancet 2001; 358: 208–209.
- 43Taylor DM, Fraser H, McConnell I, et al. Decontamination studies with the agents of bovine spongiform encephalopathy and scrapie. Arch Virol 1994; 139: 313–326.
- 44Brown P, Preece MA, Will RG. ‘Friendly fire’ in medicine: hormones, homografts, and Creutzfeldt-Jakob disease. Lancet 1992; 340: 24–27.
- 45Glatzel M, Abela E, Maissen M, Aguzzi A. Extraneural pathologic prion protein in sporadic Creutzfeldt-Jakob disease. N Engl J Med 2003; 349: 1812–1820.
- 46Kovacs GG, Lindeck-Pozza E, Chimelli L, et al. Creutzfeldt-Jakob disease and inclusion body myositis: abundant disease-associated prion protein in muscle. Ann Neurol 2004; 55: 121–125.
- 47Collins S, Law MG, Fletcher A, Boyd A, Kaldor J, Masters CL. Surgical treatment and risk of sporadic Creutzfeldt-Jakob disease: a case–control study. Lancet 1999; 353: 693–697.
- 48Ward HJ, Everington D, Croes EA, et al. Sporadic Creutzfeldt-Jakob disease and surgery: a case–control study using community controls. Neurology 2002; 59: 543–548.
- 49Hunter N, Foster J, Chong A, et al. Transmission of prion diseases by blood transfusion. J Gen Virol 2002; 83: 2897–2905.
- 50Llewelyn CA, Hewitt PE, Knight RSG, et al. Possible transmission of variant Creutzfeldt-Jakob disease by blood transfusion. Lancet 2004; 363: 417–421.
- 51Collinge J. Variant Creutzfeldt-Jakob disease. Lancet 1999; 354: 317–323.